Advertisement

Treatment of Tobacco Dependence in Alcoholics

  • Richard D. Hurt
  • Christi A. Patten
Part of the Recent Developments in Alcoholism book series (RDIA, volume 16)

Abstract

Because of the high morbidity and mortality that alcoholic smokers experience from tobacco-caused diseases, treatment for tobacco dependence among alcoholics is warranted. Much progress has been made during the last decade in addressing tobacco dependence in alcoholism treatment units. Treatment of tobacco dependence in alcoholic smokers does not seem to cause excessive relapse to drinking and, in fact, stopping smoking may enhance abstinence from drinking. Therefore, treatment for alcoholic smokers should take place whenever and wherever the patient comes in contact with the health care system. Because alcoholic smokers as a rule are more dependent on nicotine than their nonalcoholic counterparts, they may need more intensive pharmacotherapy and behavioral therapy. Because many of them have experienced 12-step approaches to recovery, that same technology can be used to initiate and maintain abstinence from tobacco use. Moreover, several pharmacologic options exist to treat tobacco dependence in alcoholic smokers. However, the efficacy of several pharmacologic therapies for alcoholic smokers needs to be tested. In addition, further research is needed on effective treatments for recovering alcoholics of various racial/ethnic backgrounds.

Keywords

Smoking Cessation Nicotine Dependence Nicotine Replacement Therapy Substance Abuse Treatment Nicotine Patch 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ascher, J.A., Cole, J.O., Colin, J.N., Feighner, J.P., Ferris, R.M., Fibiger, H.C., Golden, R.N., Martin, P., Potter, W.Z., Richelson, E., & Sulser, F. (1995). Bupropion: A review of its mechanism of anti-depressant activity. Journal of Clinical Psychiatry 56(9), 395–401.PubMedGoogle Scholar
  2. Bergström, M., Nordberg, A., Lunell, E., Antoni, G., & Långström, B. (1995). Regional deposition of inhaled 11C-nicotine vapor in the human airway as visualized by positron emission tomography. Clinical Pharmacology and Therapeutics 57(3), 309–317.PubMedGoogle Scholar
  3. Blondal, T., Gudmundsson, L.J., Olafsdottir, I., Gustavsson, G., & Westin, A. (1999). Nicotine nasal spray with nicotine patch for smoking cessation: Randomized trial with six year follow up. British Medical Journal 318, 285–288.PubMedGoogle Scholar
  4. Blot, W.J., McLaughlin, J.K., Winn, D.M., Austin, D.F., Greenberg, R.S., Preston-Martin, S., Berstein, L., Schnoenberg, J.B., Sternhagen, A., & Faurmeni, J.F. (1988). Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Research 48, 3283–3287.Google Scholar
  5. Bobo, J.K. (1989). Nicotine dependence and alcoholism epidemiology and treatment. Journal of Psychoactive Drugs 21, 323–329.PubMedGoogle Scholar
  6. Bobo, J.K., McIlvain, H.E., Gilchrist, L.D., & Bowman, A. (1996). Nicotine dependence and intentions to quit smoking in three samples of male and female recovering alcoholics and problem drinkers. Substance Use and Misuse 31, 17–33.PubMedGoogle Scholar
  7. Bobo, J.K., McIlvain, H.E., Lando, H.A., Walker, R.D., & Leed-Kelly, A. (1998). Effect of smoking cessation counseling on recovery from alcoholism: Findings from a randomized community intervention trial. Addiction 93, 877–887.PubMedCrossRefGoogle Scholar
  8. Bobo, J.K., Schilling, R.F., Gilchrist, L.D., & Schinke, S.P. (1986). The double triumph: Sustained sobriety and successful cigarette smoking cessation. Journal of Substance Abuse Treatment 3, 21–35.PubMedCrossRefGoogle Scholar
  9. Bohadana, A., Nilsson, F., Rasmussen, T., & Martinet, Y. (2000). Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation. A randomized, double-blind, placebocontrolled trial. Archives of Internal Medicine 160, 3128–3134.PubMedCrossRefGoogle Scholar
  10. Breslau, N., Kilbey, M., & Andreski, P. (1991). Nicotine dependence, major depression, and anxiety in young adults. Archives of General Psychiatry 48, 1069–1074.PubMedGoogle Scholar
  11. Breslau, N., Kilbey, M., & Andreski, P. (1993). Nicotine dependence and major depression. New evidence from a prospective investigation. Archives of General Psychiatry 50, 31–35.PubMedGoogle Scholar
  12. Breslau, N., Peterson, E., Schultz, L., Andreski, P., & Chilcoat, H. (1996). Are smokers with alcohol disorders less likely to quit? American Journal of Public Health 86(7), 985–990.PubMedGoogle Scholar
  13. Burling, T.A., Marshall, G.D., & Seidner, A.L. (1991). Smoking cessation for substance abuse inpatients. Journal of Substance Abuse 3, 269–276.PubMedCrossRefGoogle Scholar
  14. Burling, T.A., Ramsey, T.G., Seidner, A.L., & Kondo, C.S. (1997). Issues related to smoking cessation among substance abusers. Journal of Substance Abuse 9, 27–40.PubMedCrossRefGoogle Scholar
  15. Burling, T.A., Seidner, A.L., & Ramsey, T. (1997). A controlled trial of stop-smoking treatment for drug/alcohol dependent patients. Paper presented at the Annual Meeting of the Society of Behavioral Medicine, San Francisco, CA.Google Scholar
  16. Burling, T.A., & Ziff, D.C. (1988). Tobacco smoking: A comparison between alcohol and drug abuse in patients. Addictive Behaviors 13(2), 185–190.PubMedCrossRefGoogle Scholar
  17. Carmelli, D., Swan, G.E., & Robinette, D. (1993). The relationship between quitting smoking and changes in drinking in World War II veteran twins. Journal of Substance Abuse Treatment 5, 103–116.Google Scholar
  18. Centers for Disease Control and Prevention. (1999). Achievements in public health, 1900–1999: Tobacco use—United States, 1900–1999. Morbidity and Mortality Weekly Report 48(43), 986–993.Google Scholar
  19. Chengappa, K.N.R., Kambhampati, R.K., Perkins, K.A., Nigam, R., Anderson, T., Brar, J.S., Vermulapalli, H.K., Alzert, R., Key, P., & Levine, J. (in press). Bupropion SR as a smoking cessation treatment in remitted depressed patients maintained on selective serotonin reuptake inhibitor antidepressants. Journal of Clinical Psychiatry.Google Scholar
  20. Choi, W.S., Patten, C.A., Gillin, J.C., Kaplan, R.M., & Pierce, J.P. (1997). Cigarette smoking predicts development of depressive symptoms among U.S. adolescents. Annals of Behavioral Medicine 19, 42–50.PubMedGoogle Scholar
  21. Clarke, P.B. (1993). Nicotine dependence—mechanisms and therapeutic strategies. Biochemical Society Symposia 59, 83–95.Google Scholar
  22. Colby, S.M., Monti, P.M., Rohsenow, D.J., Sirota, A.D., Abrams, D.B., & Niaura, R.S. (1994). Alcoholics’ beliefs about quitting smoking during alcohol treatment: Do they make a difference? Paper presented at the Annual Meeting of the Research Society on Alcoholism, Maui, Hawaii.Google Scholar
  23. Cornelius, J.R., Salloum, I.M., Ehler, J.G., Jarrett, P.J., Cornelius, M.D., Black, A., Perel, J.M., & Thase, M.E. (1997). Double-blind fluoxetine in depressed alcoholic smokers. Psychopharmacology Bulletin 33, 165–170.PubMedGoogle Scholar
  24. Covey, L.S., Glassman, A.H., & Stetner, F. (1990). Depression and depressive symptoms in smoking cessation. Comprehensive Psychiatry 31, 350–354.PubMedCrossRefGoogle Scholar
  25. Covey, L.S., Glassman, A.H., & Stetner, F. (1999). Naltrexone effects on short-term and long-term smoking cessation. Journal of Addictive Diseases 18(1), 31–40.PubMedGoogle Scholar
  26. Covey, L.S., Glassman, A.H., Stetner, E, & Becker, J.B. (1993). Effect of history of alcoholism or major depression on smoking cessation. American Journal of Psychiatry 150 (10), 1546–1547.PubMedGoogle Scholar
  27. Covey, L.S., Hughes, D.C., Glassman, A.H., Blazer, D.G., & George, L.K. (1994). Ever-smoking, quitting, and psychiatric disorders: Evidence from the Durham, North Carolina, Epidemiologic Catchment Area. Tobacco Control 3, 222–227.Google Scholar
  28. Cox, L.S., Patten, C.A., Niaura, R.S., Wolter, T.D., Hays, J.T., Rigotti, N., Sachs, D.P.L., Buist, A.S., Hurt, R.D., Croghan, I.T., & Offord, K.P. (in press). Efficacy of bupropion for relapse prevention in smokers with a past history of major depression or alcoholism. Journal of Clinical Psychiatry. Google Scholar
  29. Craig, T.J., & Vannatta, P.A. (1977). The association of smoking and drinking habits in a community sample. Journal of Studies on Alcohol 38, 1434–1439.PubMedGoogle Scholar
  30. Dale, L.C., Hurt, R.D., Offord, K.P., Lawson, G.M., Croghan, I.T., & Schroeder, D.R. (1995). Highdose nicotine patch therapy: Percentage of replacement and smoking cessation. Journal of the American Medical Association 274(17), 1353–1358.PubMedCrossRefGoogle Scholar
  31. De Soto, C.B., O’Donnell, WE., & De Soto, J.L. (1989). Long-term recovery in alcoholics. Alcoholism, Clinical and Experimental Research 13(5), 693–697.PubMedGoogle Scholar
  32. DiChiara, G., & Imperato, A. (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proceedings of the National Academy of Sciences of the United States of America 85(14), 5274–5278.Google Scholar
  33. DiFranza, J.R., & Guerrera, M.P. (1989). Hardcore smokers (letter). Journal of the American Medical Association 261(18), 2634–2635.PubMedCrossRefGoogle Scholar
  34. DiFranza, J.R., & Guerrera, M.P. (1990). Alcoholism and smoking. Journal of Studies on Alcohol 51, 130–135.Google Scholar
  35. Ellingstad, T.P., Sobell, L.C., Sobell, M.B., Cleland, P.A., & Agrawal, S. (1999). Alcohol abusers who want to quit smoking: Implications for clinical treatment. Drug & Alcohol Dependence 54, 259–265.Google Scholar
  36. Engelmann, J. (1989). Twelve Steps for Tobacco Users. For Recovering People Addicted to Nicotine. Center City, MN: Hazelden Foundation.Google Scholar
  37. Fagerström, K.O., Schneider, N.G., & Lunell, E. (1993). Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms. Psychopharmacology 111, 271–277.PubMedGoogle Scholar
  38. Fiore, M.C., Bailey, W.C., Cohen, S.J., Dorfman, S.F., Goldstein, M.G., Gritz, E.R., Heyman, R.B., Jaen, C.R., Kottke, T.E., Lando, H.A., Mecklenburg, R.E., Mullen, P.D., Nett, L.M., Robinson, L., Stitzer, M.L., Tommasello, A.C., Villejo, L., & Wewers, M.E. (2000). Treating Tobacco Use and Dependence. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service.Google Scholar
  39. Fiore, M.C., Smith, S.S., Jorenby, D.E., & Baker, T.B. (1994). The effectiveness of the nicotine patch for smoking cessation: A meta-analysis. Journal of the American Medical Association 271(24), 1940–1947.PubMedCrossRefGoogle Scholar
  40. Fredrickson, P.A., Hurt, R.D., Lee, G.M., Wingender, L., Croghan, I.T., Lauger, G., Gomez-Dahl, L., & Offord, K.P. (1995). High dose transdermal nicotine therapy for heavy smokers: Safety, tolerability and measurement of nicotine and cotinine levels. Psychopharmacology 122, 215–222.PubMedCrossRefGoogle Scholar
  41. Fryer, J.D., & Lukas, R.J. (1999). Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine and ibogaine. Journal of Pharmacology and Experimental Therapeutics 288(1), 88–92.PubMedGoogle Scholar
  42. Gariti, P., Alterman, A.I., Barber, W., Bedi, N., Luck, G., & Cnaan, A. (1999). Cotinine replacement levels for a 21 mg/day transdermal nicotine patch in an outpatient treatment setting. Drug & Alcohol Dependence 54(2), 111–116.Google Scholar
  43. Glassman, A.H., Helzer, J.E., Covey, L.S., Cottler, L.B., Stetner, F., Tipp, J.E., & Johnson, J. (1990). Smoking, smoking cessation, and major depression. Journal of the American Medical Association 264, 1546–1549.PubMedCrossRefGoogle Scholar
  44. Glassman, A.H., Stetner, F., Walsh, B.T., Raizman, P.S., Fleiss, J.L., Cooper, T.B., & Covey, L.S. (1988). Heavy smokers, smoking cessation, and clonidine: Results of a double-blind, randomized trial. Journal of the American Medical Association 259, 2863–2866.PubMedCrossRefGoogle Scholar
  45. Glover, E.D., Sachs, D.P.L., Stitzer, M.L., Rennard, S.I., Wadland, W.C., Pomerleau, O.F., Nowak, R.T., Daughton, D.M., Glover, P.N., Hughes, J.R., & Gross, J. (1996). Smoking cessation in highly dependent smokers with 4 mg nicotine polacrilex. American Journal of Health Behavior 20(5), 319–332.Google Scholar
  46. Gritz, E.R. (1994). Reaching toward and beyond the year 2000 goals for cigarette smoking. Cancer 74, 1423–1432.PubMedGoogle Scholar
  47. Gulliver, S.B., Kalman, D., Rohsenow, D.J., Colby, S.M., Eaton, C.A., & Monti, P.M. (2000). Smoking and drinking among alcoholics in treatment: Cross-sectional and longitudinal relationships. Journal of Studies on Alcohol 61, 157–163.PubMedGoogle Scholar
  48. Hajek, P., West, R., Foulds, J., Nilsson, F., Burrows, S., & Meadow, A. (1999). Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Archives of Internal Medicine 159, 2033–2038.PubMedCrossRefGoogle Scholar
  49. Hall, S.M., Reus, V., Munoz, R., Sees, K.L., Humfleet, G., Hartz, D.T., Frederick, S., & Triffleman, E. (1998). Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Archives of General Psychiatry 55, 683–690.PubMedCrossRefGoogle Scholar
  50. Hanna, E.Z., & Grant, B.F. (1999). Parallels to early onset smoking with drug use and DSM-IV drug and depressive disorders: Findings from the National Longitudinal Epidemiologic Survey. Alcoholism, Clinical and Experimental Research 23, 513–522.PubMedGoogle Scholar
  51. Hayford, K.E., Patten, C.A., Rummans, T.A., Schroeder, D.R., Offord, K.P., Croghan, I.T., Glover, E.D., Sachs, D.P.L., & Hurt, R.D. (1999). Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. British Journal of Psychiatry 174, 173–178.PubMedCrossRefGoogle Scholar
  52. Hays, J.T., Hurt, R.D., Rigotti, N.A., Niaura, R., Gonzales, D., Durcan, M.J., Sachs, D.P., Wolter, T.D., Buist, A.S., Johnston, J.A., & White, J.D. (2001). Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. A randomized, controlled trial. Annals of Internal Medicine 135, 423–433.PubMedGoogle Scholar
  53. Hays, J.T., Offord, K.P., Croghan, I.T., Patten, C.A., Schroeder, D.R., Hurt, R.D., Jorenby, D.E., & Fiore, M.C. (1999). Smoking cesstion rates in active and recovering alcoholics treated for nicotine dependence. Annals of Behavioral Medicine 21, 1–8.CrossRefGoogle Scholar
  54. Hays, J.T., Wolter, T.D., Eberman, K.M., Croghan, I.T., Offord, K.P., & Hurt, R.D. (2001). Residential (inpatient) treatment compared with outpatient treatment for nicotine dependence. Mayo Clinic Proceedings 76, 124–133.PubMedGoogle Scholar
  55. Hughes, J.R. (1993). Treatment of smoking cessation in smokers with past alcohol/drug problems. Journal of Substance Abuse Treatment 10, 181–187.PubMedCrossRefGoogle Scholar
  56. Hughes, J.R. (1995). Treatment of nicotine dependence. Is more better? (editorial). Journal of the American Medical Association 274(17), 1390–1391.PubMedCrossRefGoogle Scholar
  57. Hughes, J.R. (1996). Clinical implications of the association between smoking and alcoholism. In J.B. Fertig & J.P. Allen (eds.), Alcohol and Tobacco: From Basic Science to Clinical Practice, NIAAA Research Monograph 30. Washington, D.C.: U.S. Government Printing Office, pp. 171–185.Google Scholar
  58. Hughes, J.R., Lesmes, G.R., Hatsukami, D.K., Richmond, R.L., Lichtenstein, E., Jorenby, D.E., Broughton, J.O., Fortmann, S.P., Leischow, S.J., McKenna, J.P., Rennard, S.I., Wadland, W.C., & Heatley, S.A. (1999). Are higher doses of nicotine replacement more effective for smoking cessation? Nicotine and Tobacco Research 1, 169–174.PubMedGoogle Scholar
  59. Hughes, J.R., Rose, G.L., & Callas, P.W. (2000). Nicotine is more reinforcing in smokers with past alcoholism than in smokers without this history. Alcoholism, Clinical and Experimental Research 24, 1633–1638.PubMedGoogle Scholar
  60. Hurt, R.D., Ahlskog, E., Croghan, G.A., Offord, K.P., Wolter, T.D., Croghan, I.T., & Moyer, T.P. (2000). Carbidopa/levodopa for smoking cessation: A pilot study with negative results. Nicotine and Tobacco Research 2, 71–78.PubMedGoogle Scholar
  61. Hurt, R.D., Croghan, I.T., Offord, K.P., Eberman, K.M., & Morse, R.M. (1995). Attitudes toward nicotine dependence among chemical dependency unit staff: Before and after a smoking cessation trial. Journal of Substance Abuse Treatment 12(4), 247–252.PubMedCrossRefGoogle Scholar
  62. Hurt, R.D., Dale, L.C., Fredrickson, P.A., Caldwell, C.C., Lee, G.M., Offord, K.P., Lauger, G.G., Marusic, Z., Neese, L.W., & Lundberg, T.G. (1994). Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up—one-year outcome and percentage nicotine replacement. Journal of the American Medical Association 271(8), 595–600.PubMedCrossRefGoogle Scholar
  63. Hurt, R.D., Dale, L.C., Offord, K.P., Bruce, B.K., McClain, F.L., & Eberman, K.M. (1992). Inpatient treatment of severe nicotine dependence. Mayo Clinic Proceedings 67, 823–828.PubMedGoogle Scholar
  64. Hurt, R.D., Dale, L.C., Offord, K.P., Croghan, I.T., Hays, J.T., & Gomez-Dahl, L. (1995). Nicotine patch therapy for smoking cessation in recovering alcoholics. Addiction 90, 1541–1546.PubMedGoogle Scholar
  65. Hurt, R.D., Dale, L.C., Offord, K.P., Lauger, G.G., Baskin, L.B., Lawson, G.M., Jiang, N.S., & Hauri, P.J. (1993). Serum nicotine and cotinine levels during nicotine patch therapy. Clinical Pharmacology and Therapeutics 54(1), 98–106.PubMedGoogle Scholar
  66. Hurt, R.D., Eberman, K.M., Croghan, I.T., Offord, K.P., Davis, L.J., Morse, R.M., Palmen, M.A., & Bruce, B.K. (1994). Nicotine dependence treatment during inpatient treatment for other addictions: A prospective intervention trial. Alcoholism Clinical and Experimental Research 18(4), 867–872.Google Scholar
  67. Hurt, R.D., Eberman, K.M., Slade, J., & Karan, I. (1993). Treating nicotine dependence in patients with other addictive disorders. In C. T. Orleans & J. Slade (eds.), Nicotine Addiction: Principles and Management. New York: Oxford University Press, pp. 310–326.Google Scholar
  68. Hurt, R.D., Finlayson, R.E., Morse, R.M., & Davis, L.J. (1988). Alcoholism in elderly persons: Medical aspects and prognosis in 216 inpatients. Mayo Clinic Proceedings 63, 753–760.PubMedGoogle Scholar
  69. Hurt, R.D., Offord, K.P., Croghan, G.A., Croghan, I.T., Gomez-Dahl, L., Wolter, T.D., Dale, L.C., & Moyer, T.P. (1998). Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms. Psychopharmacology 140, 98–104.PubMedCrossRefGoogle Scholar
  70. Hurt, R.D., Offord, K.P., Croghan, I.T., Gomez-Dahl, L., Kottke, T.E., Morse, R.M., & Melton, L.J.I. (1996). Mortality following inpatient addictions treatment: Role of tobacco use in a community-based cohort. Journal of the American Medical Association 275(14), 1097–1103.PubMedCrossRefGoogle Scholar
  71. Hurt, R.D., Sachs, D.P.L., Glover, E.D., Offord, K.P., Johnston, J.A., Dale, L.C., Khayrallah, M.A., Schroeder, D.R., Glover, P.N., Sullivan, C.R., Croghan, I.T., & Sullivan, P.M. (1997). A comparison of sustained-release bupropion and placebo for smoking cessation. New England Journal of Medicine 337, 1195–1202.PubMedCrossRefGoogle Scholar
  72. Hutchison, K.E., Monti, P.M., Rohsenow, D.J., Swift, R.M., Colby, S.M., Gnys, M., Niaura, R.S., & Sirota, A.D. (1999). Effects of naltrexone with nicotine replacement on smoking cue reactivity: Preliminary results. Psychopharmacology 142, 139–143.PubMedCrossRefGoogle Scholar
  73. Johnston, J.A., Lineberry, C.G., Ascher, J.A., Davidson, J., Khayrallah, M.A., Feighner, J.P., & Stark, P. (1991). A 102-center prospective study of seizure in association with bupropion. Journal of Clinical Psychiatry 52(11), 450–456.PubMedGoogle Scholar
  74. Jorenby, D.E., Leischow, S.J., Nides, M., Rennard, S.I., Johnston, J.A., Hughes, A.R., Smith, S.S., Muramoto, M.L., Daughton, D.M., Doan, K., Fiore, M.C., & Baker, T.B. (1999). A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. New England Journal of Medicine 340(9), 685–691.PubMedCrossRefGoogle Scholar
  75. Jorenby, D.E., Smith, S.S., Fiore, M.C., Hurt, R.D., Offord, K.P., Croghan, I.T., Hays, J.T., Lewis, S.F., & Baker, T.B. (1995). Varying nicotine patch dose and type of smoking cessation counseling. Journal of the American Medical Association 274(17), 1347–1352.PubMedCrossRefGoogle Scholar
  76. Joseph, A.M., Nichol, K.L., Willenbring, M.L., Korn, J.E., & Lysaght, L.S. (1990). Beneficial effects of treatment of nicotine dependence during an inpatient substance abuse treatment program. Journal of the American Medical Association 263, 3043–3046.PubMedCrossRefGoogle Scholar
  77. Joseph, A.M., Willenbring, M.L., Nugent, S.M., & Nelson, D. (in press). Timing of Alcohol and Smoking Cessation (TASC): Study design, screening results and baseline characteristics.Google Scholar
  78. Kalman, D., Hayes, K., Colby, S.M., Eaton, C.A., Rohsenow, D.J., & Monti, P.M. (2001). Concurrent versus delayed smoking cessation treatment for persons in early alcohol recovery: A pilot study. Journal of Substance Abuse Treatment 20, 233–238.PubMedCrossRefGoogle Scholar
  79. Kandel, D., Chen, K., Warner, L.A., Kessler, R.C., & Grant, B. (1997). Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the U.S. population. Drug and Alcohol Dependence 44, 11–29.PubMedCrossRefGoogle Scholar
  80. Keenan, R.M., Hatsukami, D.K., Pickens, R.W., Gust, S.W., & Strelow, L.J. (1990). The relationship between chronic ethanol exposure and cigarette smoking in the laboratory and the natural environment. Psychopharmacology 100, 77–83.PubMedGoogle Scholar
  81. Kendler, K.S., Neale, M.C., MacLean, C.J., Heath, C.W., Jr., Eaves, L.J., & Kessler, R.C. (1993). Smoking and major depression: A casual analysis. Archives of General Psychiatry 50, 36–43.PubMedGoogle Scholar
  82. Kenford, S.L., Fiore, M.C., Jorenby, D.E., Smith, S.S., Wetter, D., & Baker, T.B. (1994). Predicting smoking cessation. Who will quit with and without the nicotine patch. Journal of the American Medical Association 271(8), 589–594.PubMedCrossRefGoogle Scholar
  83. Kessler, R.C., Nelson, C.B., McGonagle, K.A., Edlund, M.J., Frank, R.G., & Leaf, P.J. (1996). The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. American Journal of Orthopsychiatry 66(1), 17–31.PubMedGoogle Scholar
  84. Kornitzer, M., Boutsen, M., Dramaix, M., Thijs, J., & Gustavsson, G. (1995). Combined use of nicotine patch and gum in smoking cessation: A placebo-controlled clinical trial. Preventive Medicine 24(1), 41–47.PubMedCrossRefGoogle Scholar
  85. Kozlowski, L.T., Henningfield, J.E., Keenan, R.M., Lei, H., Leigh, G., Jelinek, L.C., Pope, M.A., & Haertzen, C.A. (1993). Patterns of alcohol, cigarette, and caffeine and other drug use in two drug abusing populations. Journal of Substance Abuse Treatment 10, 171–179.PubMedCrossRefGoogle Scholar
  86. Kozlowski, L.T., Jelinek, L.C., & Pope, M.A. (1986). Cigarette smoking among alcohol abusers: A continuing and neglected problem. Canadian Journal of Public Health 77, 205–207.Google Scholar
  87. Kozlowski, L.T., Skinner, W., Kent, C, & Pope, MA. (1989). Prospects for smoking treatment in individuals seeking treatment for alcohol and other drug problems. Addictive Behaviors 14, 273–278.PubMedGoogle Scholar
  88. Kozlowski, L.T., Wilkinson, A., Skinner, W., Kent, C., & Franklin, T. (1989). Comparing tobacco cigarette dependence with other drug dependencies: Greater or equal “difficulty quitting” and “urges to use,” but less “pleasure” from cigarettes. Journal of the American Medical Association 261, 898–901.PubMedCrossRefGoogle Scholar
  89. Lawson, G.M., Hurt, R.D., Dale, L.C., Offord, K.P., Croghan, I.T., Schroeder, D.R., & Jiang, N.S. (1998a). Application of serum nicotine and plasma cotinine concentrations to assess nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy. Journal of Clinical Pharmacology 38(6), 502–509.PubMedGoogle Scholar
  90. Lawson, G.M., Hurt, R.D., Dale, L.C., Offord, K.P., Croghan, I.T., Schroeder, D.R., & Jiang, N.S. (1998b). Application of urine nicotine and cotinine excretion rates to assess nicotine replacement in light, moderate and heavy smokers undergoing transdermal therapy. Journal of Clinical Pharmacology 38(6), 510–516.PubMedGoogle Scholar
  91. Leischow, S.J., Nilsson, F., Franzon, M., Hill, A., Otte, P., & Merikle, E.P. (1996). Efficacy of the nicotine inhaler as an adjunct to smoking cessation. American Journal of Health and Behavior 20(5), 364–371.Google Scholar
  92. Lunell, E., Bergström, M., Antoni, G., Långström, B., & Nordberg, A. (1996). Nicotine deposition and body distribution from a nicotine inhaler and a cigarette studied with positron emission tomography (letter to editor). Clinical Pharmacology and Therapeutics 59(5), 593–594.PubMedGoogle Scholar
  93. Lunell, E., Molander, L., Ekberg, K., & Wahren, J. (2000). Site of nicotine absorption from a vapour inhaler-comparison with cigarette smoking. European Journal of Clinical Pharmacology 55(10), 737–741.PubMedCrossRefGoogle Scholar
  94. Maletzky, B.M., & Klotter, J. (1974). Smoking and alcoholism. American Psychologist 131, 445–447.Google Scholar
  95. Marks, J.L., Hill, E.M., Pomerleau, C.S., Mudd, S.A., & Blow, EC. (1997). Nicotine dependence and withdrawal in alcoholic and nonalcoholic ever-smokers. Journal of Substance Abuse Treatment 14, 521–527.PubMedCrossRefGoogle Scholar
  96. Martin, J.E., Calfas, K.J., Patten, C.A., Polarek, M., Hofstetter, C.R., Noto, J., & Beach, D. (1997). Prospective evaluation of three smoking interventions in 205 recovering alcoholics: One-year results of Project SCRAP-Tobacco. Journal of Consulting and Clinical Psychology 65(1), 190–194.PubMedCrossRefGoogle Scholar
  97. McGinnis, J.M., & Foege, W.H. (1993). Actual causes of death in the United States. Journal of the American Medical Association 270, 2207–2212.PubMedCrossRefGoogle Scholar
  98. McIlvain, H.E., Bobo, J.K., Leed-Kelly, A., & Sitorius, M.A. (1998). Practical steps to smoking cessation for recovering alcoholics. American Family Physician 57, 1869–1876+.PubMedGoogle Scholar
  99. Miller, W.R., & Cervantes, E.A. (1997). Gender and patterns of alcohol problems: Pretreatment responses of women and men to the comprehensive drinker profile. Journal of Clinical Psychology 53, 263–277.PubMedCrossRefGoogle Scholar
  100. Miller, W.R., Hedrick, K.E., & Taylor, C.A. (1983). Addictive behaviors and life problems before and after behavioral treatment of problem drinkers. Addictive Behaviors 8, 403–412.PubMedCrossRefGoogle Scholar
  101. Mirand, A.L., & Welte, J.W. (1996). Alcohol consumption among the elderly in a general population, Erie County, New York. American Journal of Public Health 86, 978–984.PubMedCrossRefGoogle Scholar
  102. Myers, M., & Brown, S. (1994). Smoking and health in substance abusing adolescents: A two-year follow-up. Pediatrics 93, 561–566.PubMedGoogle Scholar
  103. Myers, M.G., & Brown, S.A. (1997). Cigarette smoking four years following treatment for adolescent substance abuse. Journal of Child and Adolescent Substance Abuse 7, 1–15.Google Scholar
  104. Myers, M.G., Brown, S.A., & Kelly, J.F. (2000). A smoking intervention for substance abusing adolescents: Outcomes, predictors of cessation attempts, and post-treatment substance use. Journal of Child and Adolescent Substance Abuse 9, 77–91.Google Scholar
  105. Myers, M.G., Brown, S.A., & Kelly, J.F. (in press). A cigarette smoking intervention for substance abusing adolescents. Cognitive and behavioral practice.Google Scholar
  106. Myers, M.G., Kelly, J.E, & Lennox, G.A. (1997). Nicotine dependence and motivation for smoking cessation among substance abusing adolescents. Paper presented at the Society of Behavioral Medicine Annual Meeting, San Francisco, CA, April 1997.Google Scholar
  107. Novy, P.L., Hughes, J.R., Jensen, J.A., Hatsukami, D.K., & Huston, J. (1999). The efficacy of the nicotine patch in recovering alcoholic smokers. In L. Harris (ed.), Problems of Drug Dependence 1998, NIDA Research Monograph 179 (Vol. 91). Washington, DC: USDHHS.Google Scholar
  108. Orleans, C.T., & Hutchinson, D. (1993). Tailoring nicotine addiction treatments for chemical dependency patients. Journal of Substance Abuse Treatment 10, 197–208.PubMedCrossRefGoogle Scholar
  109. Paoletti, P., Fornai, E., Maggiorelli, F., Puntoni, R., Viegi, G., Carrozzi, L., Corlando, A., Gustavsson, G., Säwe, U., & Giuntini, C. (1996). Importance of baseline cotinine plasma values in smoking cessation: Results from a double-blind study with nicotine patch. European Respiratory Journal 9, 643–651.PubMedCrossRefGoogle Scholar
  110. Patten, C.A., Drews, A., Myers, M.G., Martin, J.E., & Wolter, T.D. (in press). Effect of depressive symptoms on smoking abstinence among alcohol dependent smokers. Psychology of Addictive Behaviors.Google Scholar
  111. Patten, C.A., Martin, J.E., Calfas, K.J., Lento, J., & Wolter, T.D. (2001). Behavioral treatment for smokers with a history of alcoholism: Predictors of successful outcome. Journal of Consulting and Clinical Psychology 69(5), 796–801.PubMedCrossRefGoogle Scholar
  112. Patten, C.A., Martin, J.E., Hofstetter, C.R., Brown, S.A., Kim, N., & Williams, C. (1999). Smoking cessation following treatment in a smoke-free Navy alcohol rehabilitation program. Journal of Substance Abuse Treatment 16, 61–69.PubMedCrossRefGoogle Scholar
  113. Patten, C.A., Martin, J.E., Myers, M.G., Calfas, K.J., & Williams, C.D. (1998). Effectiveness of cognitive-behavioral therapy for smokers with histories of alcohol dependence and depression. Journal of Studies on Alcohol 59, 327–335.PubMedGoogle Scholar
  114. Patten, C.A., Martin, J.E., & Owen, N. (1996). Can psychiatric and chemical dependency treatment units be smoke free? Journal of Substance Abuse Treatment 13, 107–118.PubMedCrossRefGoogle Scholar
  115. Patten, C.A., Schneekloth, T.D., Morse, R.M., Herrick, L.M., Offord, K.P., Wolter, T.D., Williams, B.A., & Hurt, R.D. (2001). Effect of current tobacco use and history of an alcohol problem on health status in hospitalized patients. Addictive Behaviors 26, 129–136.PubMedCrossRefGoogle Scholar
  116. Pontieri, F.E., Tanda, G., Orzi, F., & DiChiara, G. (1996). Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382, 255–257.PubMedCrossRefGoogle Scholar
  117. Prochazka, A.V., Weaver, M.J., Keller, R.T., Fryer, G.E., Licari, P.A., & Lofaso, D. (1998). A randomized trial of nortriptyline for smoking cessation. Archives of Internal Medicine 158, 2035–2039.PubMedCrossRefGoogle Scholar
  118. Ravenholt, R.T. (1984). Addictionmortality in the United States. Population and Development Review 4, 697–725.Google Scholar
  119. Regier, D.A., Farmer, M.E., Rae, D.S., Locke, B.Z., Keith, S.J., Judd, L.L., & Goodwin, K.K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Journal of the American Medical Association 264, 2511–2518.PubMedCrossRefGoogle Scholar
  120. Robertson, N. (1988). Getting Better: Inside Alcoholics Anonymous. New York: William Morrow.Google Scholar
  121. Rohsenow, D.J., Monti, P.M., Colby, S.M., Gulliver, S.B., Sirota, A.D., Niaura, R.S., & Abrams, D.B. (1997). Effects of alcohol cues on smoking urges and topography among alcoholic men. Alcoholism, Clinical and Experimental Research 21, 101–107.PubMedGoogle Scholar
  122. Rose, J.E., Behm, F.M., Westman, E.C., Levin, E.D., Stein, R.M., & Ripka, G.V. (1994). Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone. Clinical Pharmacology and Therapeutics 56(1), 86–99.PubMedGoogle Scholar
  123. Rose, J.E., Westman, E.C., & Behm, F.M. (1996). Nicotine/mecamylamine combination treatment for smoking cessation. Drug Development Research 38, 243–256.CrossRefGoogle Scholar
  124. Russell, M.A.H., Raw, M., & Jarvis, M.J. (1980). Clinical use of nicotine chewing gum. British Medical Journal 280, 1599–1602.PubMedGoogle Scholar
  125. Rustin, T.A. (1998). Incorporating nicotine dependence into addiciton treatment. Journal of Addictive Diseases 17, 83–108.PubMedCrossRefGoogle Scholar
  126. Sachs, D.P.L. (1995). Effectiveness of the 4-mg dose of nicotine polacrilex for the initial treatment of high-dependent smokers. Archives of Internal Medicine 155, 1973–1980.PubMedCrossRefGoogle Scholar
  127. Sachs, D.P.L., Benowitz, N.L., Bostrom, A.G., & Hansen, M.D. (1995). Percent serum replacement and success of nicotine patch therapy. American Journal of Respiratory and Critical Care Medicine 151, A688.Google Scholar
  128. Saxon, A.J., McGuffin, R., & Walker, R.D. (1997). An open trial of transdermal nicotine replacement therapy for smoking cessation among alcohol-and drug-dependent inpatients. Journal of Substance Abuse Treatment 14, 333–337.PubMedCrossRefGoogle Scholar
  129. Schneider, N.G., Lunell, E., Olmstead, R.E., & Fagerström, K.O. (1996). Clinical pharmacokinetics of nasal nicotine delivery: A review and comparison to other nicotine systems. Clinical Pharmacokinetics 31(1), 65–80.PubMedCrossRefGoogle Scholar
  130. Schneider, N.G., Olmstead, R., Mody, F.V., Doan, K., Franzon, M., Jarvik, M.E., & Steinberg, C. (1995). Efficacy of a nicotine nasal spray in smoking cessation: A placebo-controlled, double-blind trial. Addiction 90(12), 1671–1682.PubMedCrossRefGoogle Scholar
  131. Schuckit, M.A. (1986). Genetic and clinical implications of alcoholism and affective disorder. American Journal of Psychiatry 143, 140–147.PubMedGoogle Scholar
  132. Schuh, K.J., Schuh, L.M., Henningfield, J.E., & Stitzer, ML. (1997). Nicotine nasal spray and vapor inhaler: Abuse liability assessment. Psychopharmacology 130(4), 352–361.PubMedGoogle Scholar
  133. Seider, A.L., Burling, T.A., Gaither, D.E., & Thomas, R.G. (1996). Substance-dependent inpatients who accept smoking treatment. Journal of Substance Abuse 8, 33–44.Google Scholar
  134. Sellers, E.M., Naranjo, C., & Kadlec, K. (1987). Do serotonin uptake inhibitors decrease smoking? Observations in a group of heavy drinkers. Journal of Clinical Psychopharmacology 7(6), 417–420.PubMedGoogle Scholar
  135. Slemmer, J.E., Martin, B.R., & Damaj, M.I. (in press). Bupropion is a nicotinic antagonist. Journal of Pharmacology and Experimental Therapeutics.Google Scholar
  136. Sobell, L.C., Sobell, M.B., & Toneatto, T. (1991). Recovery from alcohol problems without treatment. In N. Heather, W.R. Miller & J. Greeley (eds.), Self-Control and Addictive Behaviors. New York: Pergamon Press, pp. 198–242.Google Scholar
  137. Sobell, M.B., & Sobell, L.C. (1993). The longitudinal study of dual recoveries from smoking and alcohol problems. Paper presented at the Association for Advancement of Behavioral Therapy Annual Meeting.Google Scholar
  138. Sobell, M.B., Sobell, L.C., & Kozlowski, L.T. (1995). Dual recovery from alcohol and smoking problems. In J.B. Fertig & J.P. Allen (eds.), Alcohol and Tobacco: From Basic Science to Clinical Practice. Washington, D.C.: US DHHS, pp. 207–224.Google Scholar
  139. Stapleton, J.A., Russell, M.A., Feyerabend, C., Wiseman, S.M., Gustavsson, G., Sawe, U., & Wiseman, D. (1995). Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction 90, 31–42.PubMedCrossRefGoogle Scholar
  140. Sussman, S. (in press). Smoking cessation among persons in recovery. Substance Use and Misuse.Google Scholar
  141. Sutherland, G., Stapleton, J.A., Russell, M.A.H., Jarvis, M.J., Hajek, P., Belcher, M., & Feyerabend, C. (1992). Randomized controlled trial of nasal nicotine spray in smoking cessation. Lancet 340, 324–329.PubMedCrossRefGoogle Scholar
  142. Toneatto, A., Sobell, L.C., Sobell, M.B., & Kozlowski, L.T. (1995). Effect of cigarette smoking on alcohol treatment outcome. Journal of Substance Abuse 7, 245–252.PubMedCrossRefGoogle Scholar
  143. Tonnesen, P., Paoletti, P., Gustavsson, G., Russell, M.A., Saracci, R., Gulsvik, A., Rijcken, B., & Sawe, U. (1999). Higher dosage nicotine patches increase one-year smoking cessation rates: Results from the European CEASE trial. European Respiratory Journal 13, 238–246.PubMedGoogle Scholar
  144. Vaillant, G.E., Schnurr, P.P., Baron, J.A., & Gerber, P.D. (1991). A prospective study of the effects of cigarette smoking and alcohol abuse on mortality. Journal of General Internal Medicine 6, 299–304.PubMedGoogle Scholar
  145. Wong, G.Y., Wolter, T.D., Croghan, G.A., Croghan, I.T., Offord, K.P., & Hurt, R.D. (1999). A ran-domized trial of naltrexone for smoking cessation. Addiction 94(8), 1227–1237.PubMedCrossRefGoogle Scholar
  146. Zevin, S., Jacob, P., & Benowitz, N.L. (1998). Dose-related cardiovascular and endocrine effects of transdermal nicotine. Clinical Pharmacology and Therapeutics 64, 87–95.PubMedGoogle Scholar
  147. Zimmerman, R.S., Warheit, G.J., Ulcrich, P.M., & Auth, J.B. (1990). The relationship between alcohol use and attempts and success at smoking cessation. Addictive Behaviors 15, 197–207.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • Richard D. Hurt
    • 1
  • Christi A. Patten
    • 1
  1. 1.Nicotine Dependence CenterMayo Clinic and Mayo FoundationRochester

Personalised recommendations